Global Cord Blood ( (CORBF) ) has released a notification of late filing.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Global Cord Blood Corporation has announced a delay in filing its Annual Report on Form 20-F (Yearly Report) for the fiscal year ending March 31, 2025. The delay is primarily due to ongoing investigations by joint provisional liquidators into the company’s financial position, which have been in place since a court order in September 2022. The company has not provided a specific timeline for when the 2025 Annual Report will be filed. The company anticipates significant changes in financial results but cannot currently estimate the extent of these changes due to the ongoing investigations. Global Cord Blood Corporation is working to comply with regulatory requirements, as indicated by the signature of John Royle, Joint Provisional Liquidator, on the notification.
More about Global Cord Blood
Average Trading Volume: 20,141
Technical Sentiment Signal: Strong Sell
Current Market Cap: $73.65M
Learn more about CORBF stock on TipRanks’ Stock Analysis page.